Europe mycotoxin testing market is projected to register a CAGR of 7.1% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
Europe Mycotoxin Testing Market, By Type (Aflatoxins, Ochratoxins, Fusarium Toxins, Deoxynivalenol, Patulin, Penicillium Toxins, Cyclopiazonic Acid, Ergot Alkaloids, Citrinin, Sterigmatocystin, Alternaria, T-2 Toxin, Zearalenone, Others), Product Type (Devices, Reagents & Kits, Services), Technology (Chromatography Based, Immunoassay-Based, Lateral Flow Assay Based, Spectroscopy Based, Others), Sample (Food, Feed, Pharmaceuticals), End User (Research Lab, Research Institutes, Food Testing Industries, Feed Testing Industries, Other), Country (Germany, Italy, France, Spain, U.K., Turkey, Russia, Switzerland, Belgium, Netherlands, Rest of Europe) Industry Trends and Forecast to 2027
.
Some of the major factors contributing to the growth of the Europe mycotoxin testing market are:

• Raising mycotoxins production owing to humid atmospheric conditions
• Consumer awareness regarding the presence of mycotoxins

Market Players:

The key market players for Europe mycotoxin testing market are listed below:

• Bureau Veritas
• Intertek Group plc
• Eurofins Scientific
• NEOGEN Corporation, LGC Limited (A SUBSIDIARY OF KOHLBERG KRAVIS ROBERTS & CO. L.P.)
• EnviroLogix
• TÜV SÜD
• SGS SA
• Fera Science Limited (a subsidiary of Capita plc.)
• SYNLAB International GmbH
• AB Sciex Pte. Ltd.
• R-Biopharm AG,
• Bio-Check (UK) Ltd.
• Soft Flow Ltd. (A Subsidiary of FOSS GROUP)
• TLR International Laboratories
• Deltamune
• Mérieux NutriSciences
• QIMA and Romer Labs Division Holding GmbH